BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11973637)

  • 1. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
    Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM
    Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine TGFalpha expression in the regulation of initiation of human colon carcinoma growth.
    Wang D; Li W; Jiang W; Humphrey LE; Howell GM; Brattain MG
    J Cell Physiol; 1998 Dec; 177(3):387-95. PubMed ID: 9808147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TGFalpha autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor.
    Jiang D; Liang J; Humphrey LE; Yang H; Brattain MG
    J Cell Physiol; 1998 May; 175(2):174-83. PubMed ID: 9525476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of transforming growth factor alpha in determining growth factor independence.
    Awwad RA; Sergina N; Yang H; Ziober B; Willson JK; Zborowska E; Humphrey LE; Fan R; Ko TC; Brattain MG; Howell GM
    Cancer Res; 2003 Aug; 63(15):4731-8. PubMed ID: 12907656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
    Ligęza J; Ligęza J; Klein A
    Acta Biochim Pol; 2011; 58(3):391-6. PubMed ID: 21887406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective cleavage of membrane bound TGFalpha leads to enhanced activation of the EGF receptor in malignant cells.
    Yang H; Jiang D; Li W; Liang J; Gentry LE; Brattain MG
    Oncogene; 2000 Apr; 19(15):1901-14. PubMed ID: 10773880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor.
    Ouyang X; Gulliford T; Huang G; Epstein RJ
    J Cell Physiol; 1999 Apr; 179(1):52-7. PubMed ID: 10082132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells.
    Chen SC; Chou CK; Wong FH; Chang CM; Hu CP
    Cancer Res; 1991 Apr; 51(7):1898-903. PubMed ID: 2004373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor.
    Freeman JW; Mattingly CA; Strodel WE
    J Cell Physiol; 1995 Oct; 165(1):155-63. PubMed ID: 7559796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor.
    Burgaud JL; Baserga R
    Exp Cell Res; 1996 Mar; 223(2):412-9. PubMed ID: 8601418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element.
    Awwad R; Humphrey LE; Periyasamy B; Scovell W; Li W; Coleman K; Lynch M; Carboni J; Brattain MG; Howell GM
    Oncogene; 1999 Oct; 18(43):5923-35. PubMed ID: 10557079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1.
    Vardy DA; Kari C; Lazarus GS; Jensen PJ; Zilberstein A; Plowman GD; Rodeck U
    J Cell Physiol; 1995 May; 163(2):257-65. PubMed ID: 7706370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
    Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ; Houtman JC; Cha D; Bertics PJ
    J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells.
    Lee JY; Han CY; Yang JW; Smith C; Kim SK; Lee EY; Kim SG; Kang KW
    Mol Pharmacol; 2007 Oct; 72(4):1082-93. PubMed ID: 17615245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.